MLXIPL and hepatocellular carcinoma: These findings supported the hypothesis of a feedback amplification circuitry in which ChREBP-mediated p85α expression exacerbates PI3K/AKT signaling to drive HK2 expression, which then potentiates ChREBP activity to promote HCC development (Fig. 5h).